Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: SG who wrote (32389)	3/26/2005 10:17:54 PM
From: Max Fletcher	Respond to of 120415

SG, I have no specialized knowledge about DCTH other than what's available in their filings and PRs, including those related to NCI and the trials in Australia. They have had consistent positive results to date, and there are few alternatives to treating liver cancer. While I don't put a whole lot of faith in analyst reports, you can glean some background info in this report: investorshub.com I think it's a longer-term play but the possible reward, coupled with diminishing risk as more and more trials are completed makes it compelling to me. It's no lock but it's one of those that my gut says to hold tightly. Who knows though I've been wrong before. Max